• General
  • Fund News
  • Government Institutions
  • Legal & Judicial
  • Board Meetings
  • Other Language
  • Home
  • Submit News
  • Contact Us
  • About Us
Pakistan Newswire
Menu
  • General
  • Fund News
  • Government Institutions
  • Legal & Judicial
  • Board Meetings
  • Other Language
 › Boehringer Ingelheim
  • EASD: Additional Evidence Showed ABASAGLAR® (insulin glargine) Provided Safety and Efficacy Similar to Lantus®

    Web Desk September 15, 2015     Comment Closed     Business & Finance, Other Language

    Secondary analyses evaluated ABASAGLAR® in patients previously treated with Lantus® insulin glargine

    STOCKHOLM, Sept. 15, 2015 / PRNewswire — Data from secondary analyses of Phase III clinical trials showed that ABASAGLAR® (insulin glargine), Eli Lilly and Company and Boehringer …

    Read more »

  • Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product

    Web Desk December 23, 2013     No Comment     Medical/Health Care

    – New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency

    INDIANAPOLIS and INGELHEIM, Germany, Dec. 20, 2013 / PRNewswire – Eli Lilly and Company and Boehringer Ingelheim today announced that the U.S. Food and Drug …

    Read more »

Search

Calendar

April 2018
M T W T F S S
« Mar    
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Follow Us

Our Facebook Page

The strategy of the team behind “Pakistan news Wire.Net” is clear and it is to publish only authentic news as that is what the true journalism demands from any media outlet, and the “Pakistan News Wire. Net”,

[...]
  • Home
  • Submit News
  • Contact Us
  • About Us

Archives

  • General
  • Fund News
  • Government Institutions
  • Legal & Judicial
  • Board Meetings
  • Other Language
Copyright © 2012 Pakistan News Wire. All Rights Reserved.
  • Home
  • Submit News
  • Contact Us
  • About Us